A Comparison of Methodologies for Estimating Survival in Patients Treated with Second-generation Tyrosine-kinase Inhibitors (TKIs) for Chronic Myeloid Leukaemia (CML)
Abstract
Authors
B. Pennington A.J. Batty E. Clifton-Brown
B. Pennington A.J. Batty E. Clifton-Brown
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now